Freedom of Information request about ADR figures within Prince Philip Hospital for the years 2018, 2019 and 2020 (FOI-21-339)
Published 28 May 2021
© Crown copyright 2021
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-19-april/freedom-of-information-request-about-adr-figures-within-prince-philip-hospital-for-the-years-2018-2019-and-2020-foi-21-339
Dear
Thank you for your email dated 24th March 2021, where you asked for information on the following:
1) figures for ADR reporting within Prince Philip Hospital for the years 2018, 2019 and 2020
2) overall reporting for ADRs annually for each of the health boards in Wales across the same years
As per your request, from 01/01/2018 to 31/12/2020, I can confirm that we have received 34 Adverse Drug Reaction (ADR) reports reported from Prince Philip Hospital. The accuracy of the data relies on the postcode (SA14 8QF) being provided by the reporter on the original Yellow Card. Furthermore, if the postcode is incorrectly provided, the Yellow Card will not be included in this analysis. It is important to note any Yellow Card reports submitted where the reporter has only provided their email address, will not be included. Please see Table 1 below for a breakdown of the number of reports received from the hospital per year.
1. Table 1: Spontaneous suspected ADR reports received between 01/01/2018 to 31/12/2020, from Prince Philip Hospital
| Year of submission | Number of ADR reports |
|---|---|
| 2018 | 11 |
| 2019 | 11 |
| 2020 | 12 |
2. Table 2: Spontaneous suspected ADR reports received between 01/01/2018 to 31/12/2020, from local health boards in Wales.
| Health Board | Number of ADR reports in 2018 | Number of ADR reports in 2019 | Number of ADR reports in 2020 |
|---|---|---|---|
| Aneurin Bevan University Health Board | 433 | 311 | 227 |
| Betsi Cadwaladr University Health Board | 884 | 946 | 688 |
| Cardiff and Vale University Health Board | 503 | 493 | 363 |
| Cwm Taf Morgannwg University Health Board | 362 | 314 | 265 |
| Hywel Dda University Health Board | 484 | 858 | 611 |
| Powys Teaching Health Board | 59 | 53 | 57 |
| Swansea Bay University Health Board | 317 | 267 | 216 |
It is important to bear in mind the following points when interpreting Yellow Card data:
-
Reports are also received by the MHRA from pharmaceutical companies who have a legal obligation to report serious suspected ADRs relating to their products. This information should only be used for education and promotion and not be used for audit purposes.
-
Please be aware, the reporting of a particular reaction does not necessarily mean that it has been caused by a drug or vaccine. Many factors must be considered in assessing the relationship between a drug or vaccine and suspected reaction including the possible contribution of other drugs being taken, and the underlying disease.
-
Furthermore, the number of reports received should not be used as a basis for determining incidence of a reaction as neither the total number of reactions occurring, nor the number of patients using a drug or vaccine is included in this data.
I hope the information provided is helpful, but if you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Internal review requests should be submitted within two months of the date of this response; and can be addressed to this email address.
Yours sincerely,
FOI Team,
Vigilance and Risk Management of Medicines Division